Posted

CoreRx Inc. has agreed to acquire Societal CDMO, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, in a deal valued at approximately $130 million. To learn more, please check out this article from Contract Pharma.

Posted

Ginkgo Bioworks has acquired Patch Biosciences, which has built an AI platform for sequence design that enables more effective, specific, and durable genetic medicines and was backed by Andreessen Horowitz (a16z) Bio + Health, Casdin Capital, and S32. See more details on the acquisition here.

Posted

Andelyn Biosciences Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-associated vectors (AAV) therapies in its suspension platform for several programs under the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC). See more details here

Posted

Not all Managers are good Leaders.  It’s a fact that many of us have seen and experienced first hand.  They are often thought of as one in the same, but there are key differences between the two.  How can you ensure that you are a great Leader and not just a Manager?  Well, the answer… Read more »

Posted

Do you think about Company Culture when you are interviewing?  If not, you need to be.  For success with long term hiring, making sure the person can do the job is key, but what if they don’t fit with the company mission or goals?  Ignoring this fact can set you up for disappointment down the… Read more »

Posted

With the reduced amount of in person interviews and jobs, we have seen a rise in situational based questioning in interviews. It makes sense – if you can’t pick up on some of the non-verbal cues or have the person physically in your office, it helps to understand how they handle certain situations. These are… Read more »